Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
156000 participants
OBSERVATIONAL
2025-02-25
2035-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents
NCT06699940
Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents
NCT02586688
NeuroStar TMS Therapy System: Utilization and Outcomes
NCT01114477
Treatment of Major Depressive Disorder in the UK Using TMS Therapy
NCT04217837
Retrospective TMS Therapy for Adults With MDD
NCT05541302
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients treated with NeuroStar TMS
NeuroStar Advanced TMS Therapy System
non-invasive brain stimulation device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NeuroStar Advanced TMS Therapy System
non-invasive brain stimulation device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age reported and not an invalid entry
* Treatment date of November 01, 2008 or later.
Exclusion Criteria
5 Years
120 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Neuronetics
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eleanor Cole, PhD
Role: STUDY_DIRECTOR
Neuronetics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neuronetics
Malvern, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Eleanor Cole
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-10000-000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.